Movano

Movano EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Movano (MOVE) as of Nov 2, 2026 is -15.50 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -24.09 M USD — a change of -35.65% (higher).

EBITDA

-15.50 MUSD

YoY

-35.65%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Movano is 2025 -15.50 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Movano was 2024 -24.09 M USD. It decreases by -35.65% higher compared to the previous year.

The Movano EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-3.50 M USD
Jan 1, 2019
-8.51 M USD
Jan 1, 2020
-12.03 M USD
Jan 1, 2021
-20.82 M USD
Jan 1, 2022
-30.31 M USD
Jan 1, 2023
-29.53 M USD
Jan 1, 2024
-24.09 M USD
Jan 1, 2025
-15.50 M USD
The Movano EBITDA history
YEAREBITDAYoY
-15.50 MUSD-35.65%
-24.09 MUSD-18.42%
-29.53 MUSD-2.57%
-30.31 MUSD+45.59%
-20.82 MUSD+73.11%
-12.03 MUSD+41.29%
-8.51 MUSD+143.48%
-3.50 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Movano Stock analysis

What does Movano do? Movano, Inc. generates revenue through its Evie Ring, a women-focused wearable device that tracks health and wellness metrics including resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity metrics like steps and calories burned, sleep stages, and mood. The company also develops System-on-a-Chip (SoC) technology for blood pressure and continuous glucose monitoring systems, targeting medical device manufacturers. Its primary customers are health-conscious women seeking comprehensive wellness insights and medical device companies requiring specialized hardware components. Movano's revenue streams are derived from direct sales of the Evie Ring and licensing of its SoC technology to industry partners. The Evie Ring is designed specifically for women, integrating multiple health metrics into a single wearable, while the SoC technology serves as a foundational component for medical devices. Movano's product development focuses on health-focused technology, with the Evie Ring being its flagship consumer product and the SoC targeting the medical device sector. The company's business model centers on combining consumer health wearables with specialized hardware for medical applications, leveraging its expertise in health data integration. Movano is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Movano stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Movano is -15.50 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Movano changed from -24.09 M USD to -15.50 M USD, representing a -35.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Movano since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Movano historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Movano

All Key Metrics — Movano